...
首页> 外文期刊>BMC Urology >Simultaneous antegrade and retrograde endoscopic treatment of non-malignant ureterointestinal anastomotic strictures following urinary diversion
【24h】

Simultaneous antegrade and retrograde endoscopic treatment of non-malignant ureterointestinal anastomotic strictures following urinary diversion

机译:导流后顺行和逆行内镜同时治疗非恶性输尿管肠吻合狭窄

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The ureterointestinal anastomosis stricture (UAS) is a common complication of urinary diversion after radical cystectomy. For decades, open anastomotic revision remained the gold standard for the treatment of UAS. However, with the advancement in endoscopic technology, mini-invasive therapeutic approaches have been used in its management. Here, we report our experience with and long-term results of combined simultaneous antegrade and retrograde endoscopy (SARE) in the treatment of non-malignant UASs after urinary diversion in a consecutive series of patients. From March 2012 to January 2015, there were 32 consecutive patients with 32 non-malignant UASs following radical cystectomy and urinary diversion. Twenty-nine patients were treated with SARE technique and comprised the study group. Using simultaneous antegrade flexible ureteroscope combined with retrograde semi-rigid ureteroscope or nephroscope, partial or complete strictures were managed with laser incision and balloon dilation under direct visualization. A 7/12 Fr graded endopyelotomy stent was left for 3–6?months after the procedure. Success was defined as symptomatic improvement and radiographic resolution of obstruction. With a median followup of 22?months (6–36), the overall success rate for SARE was 69.0%. Twenty patients with partial stricture had a success rate of 85%, and 9 patients with complete stricture had a success rate of 33.3%. Renal function, hydronephrosis grade, stricture type, and stricture length were significant influences on the outcome (P?
机译:输尿管肠吻合狭窄(UAS)是根治性膀胱切除术后尿流改道的常见并发症。数十年来,开放式吻合术仍是治疗UAS的金标准。然而,随着内窥镜技术的发展,微创治疗方法已用于其管理。在这里,我们报告了在一系列患者中,同时进行顺行和逆行内镜联合治疗非转移性UAS的经验和长期结果(SARE)。从2012年3月至2015年1月,在行根治性膀胱切除术和尿流改道后,连续有32例患者接受了32例非恶性UAS。 29例患者接受了SARE技术治疗,并组成了研究组。使用同时顺行柔性输尿管镜结合逆行半刚性输尿管镜或肾镜,可在直接可视化下通过激光切口和球囊扩张术对部分或全部狭窄进行处理。手术后,将7/12 Fr分级的肾盂切开术支架放置3–6个月。成功的定义是症状改善和影像学上的阻塞。平均随访22个月(6–36),SARE的总体成功率为69.0%。 20例局部狭窄患者的成功率为85%,9例完全狭窄患者的成功率为33.3%。肾功能,肾积水分级,狭窄类型和狭窄长度对结局有显着影响(P <0.05)。没有观察到并发症。 SARE是一种用于UAS的安全有效的治疗方法,并且可能是完整UAS的唯一内窥镜治疗方法。尽管与开放修订相比,完全狭窄的成功率较低,但鉴于其总体发病率较低,应将其视为初始方法。对于部分狭窄,审慎的患者选择会导致较高的成功率,几乎与开放翻修相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号